Webinar: Develop Once, Access Europe: The Power of Joint Clinical Assessment (JCA)

At Parexel, we're committed to guiding you through the evolving European regulatory landscape. Join us as we delve into the Joint Clinical Assessment (JCA) process and its profound impact on market access strategies.

Why Attend?

Understanding and adapting to JCA is crucial for success in the European market. This webinar will equip you with actionable insights to navigate this new paradigm effectively.

Key Topics:

1. Introduction to JCA
   • Understand the fundamentals and implications of JCA
   • Learn how JCA is reshaping the European regulatory landscape
2. HTA-proofing Development
   • Discover how JCA impacts early trial design
   • Strategies for aligning clinical development with HTA requirements
3. Beyond Efficacy: Integrating Value into EMA Assessment
   • Learn techniques for incorporating value propositions into regulatory submissions
   • Understand how to balance efficacy data with value demonstrations
4. Bridging the Gap to HTA Acceptance
   • Explore strategies to align regulatory approvals with HTA expectations
   • Learn how JCA can streamline the path from EMA approval to HTA acceptance

Featured Expert:

Dr. Sinan B. Sarac, Senior Vice President, Head of Regulatory Strategy Europe

With extensive experience in European regulatory strategy, Dr. Sarac will provide invaluable insights to optimize your approach in this new regulatory environment.

Who should attend:

• Pharmaceutical and biotech leaders
• Regulatory affairs professionals
• Clinical development teams
• Health Technology Assessment specialists

At Parexel, we believe in empowering our partners with knowledge that drives innovation. Join us to stay ahead of the curve and transform your European regulatory strategy.